JNJ-38158471
CAS: 951151-97-6
Ref. 3D-BNB15197
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
JNJ-38158471 is a tyrosine kinase inhibitor that has been shown to have anticancer activity. It can be used for the treatment of cancers, including primary resistance. JNJ-38158471 modulates the activity of growth factors, such as vascular endothelial growth factor and hepatocyte growth factor, which are involved in tumor angiogenesis and tumor cell proliferation. This drug also interacts with factor receptors on cells, which may lead to the termination of their signaling pathways. The oral formulation of JNJ-38158471 has been found to be safe and well tolerated in preclinical studies in mice. This drug is also selective for cancer cells, not affecting normal cells.
Chemical properties
Technical inquiry about: 3D-BNB15197 JNJ-38158471
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
